SART1
Gene Information
- Official Symbol: SART1
- Official Name: spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP
- Aliases and Previous Symbols: N/A
- Entrez ID: 9092
- UniProt: O43290
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Plays a role in mRNA splicing as a component of the U4/U6-U5 tri-snRNP, one of the building blocks of the spliceosome. May also bind to DNA. {ECO:0000269|PubMed:11350945}.
Pfam Domains GO Terms
Pfam Domains
| SART-1 |
GO Terms
| maturation of 5S rRNA |
| positive regulation of cytotoxic T cell differentiation |
| regulation of cytotoxic T cell differentiation |
| mRNA cis splicing, via spliceosome |
| U4/U6 x U5 tri-snRNP complex |
| spliceosomal snRNP assembly |
| U2-type precatalytic spliceosome |
| Cajal body |
| positive regulation of T cell differentiation |
| catalytic step 2 spliceosome |
| positive regulation of lymphocyte differentiation |
| regulation of T cell differentiation |
| positive regulation of leukocyte differentiation |
| regulation of lymphocyte differentiation |
| positive regulation of hemopoiesis |
| positive regulation of T cell activation |
| rRNA processing |
| positive regulation of leukocyte cell-cell adhesion |
| rRNA metabolic process |
| ribonucleoprotein complex assembly |
| ribonucleoprotein complex subunit organization |
| positive regulation of cell-cell adhesion |
| regulation of leukocyte differentiation |
| regulation of leukocyte cell-cell adhesion |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| mRNA splicing, via spliceosome |
| ribosome biogenesis |
| RNA splicing, via transesterification reactions |
| regulation of T cell activation |
| positive regulation of lymphocyte activation |
| ncRNA processing |
| regulation of cell-cell adhesion |
| RNA splicing |
| nuclear speck |
| positive regulation of cell adhesion |
| positive regulation of leukocyte activation |
| positive regulation of cell activation |
| regulation of hemopoiesis |
| ribonucleoprotein complex biogenesis |
| ncRNA metabolic process |
| mRNA processing |
| regulation of lymphocyte activation |
| regulation of leukocyte activation |
| regulation of cell activation |
| regulation of cell adhesion |
| mRNA metabolic process |
| cellular protein-containing complex assembly |
| RNA processing |
| positive regulation of cell differentiation |
| Golgi apparatus |
| positive regulation of immune system process |
| positive regulation of developmental process |
| RNA binding |
| protein-containing complex assembly |
| regulation of immune system process |
| RNA metabolic process |
| positive regulation of multicellular organismal process |
| regulation of cell differentiation |
| protein-containing complex subunit organization |
| gene expression |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| RPL35 | 0.514 |
| POLE | 0.503 |
| TICRR | 0.502 |
| ATP6V1A | 0.5 |
| POLR2J3 | 0.5 |
| NUPL1 | 0.494 |
| TBC1D3H | 0.49 |
| PSMB4 | 0.483 |
| TBC1D3F | 0.479 |
| PSMD3 | 0.478 |
| SUPT5H | 0.473 |
| NUP160 | 0.472 |
| SLC6A17 | 0.464 |
| WDR75 | 0.462 |
| RNF113A | 0.46 |
| TCEB3C | 0.459 |
| NGDN | 0.452 |
| TBC1D3G | 0.451 |
| CTAGE4 | 0.451 |
| SF3A1 | 0.451 |
| TCEB3CL | 0.45 |
| TIMELESS | 0.45 |
| PWP2 | 0.447 |
| STIL | 0.445 |
| PSMA6 | 0.445 |
| RAD51 | 0.444 |
| EXOSC9 | 0.443 |
| RRP15 | 0.443 |
| CBWD3 | 0.442 |
| RELT | 0.442 |
| TBC1D3 | 0.442 |
| PAN3 | 0.441 |
| CHD4 | 0.441 |
| TCEB3CL2 | 0.44 |
| MPHOSPH10 | 0.439 |
| FAM25B | 0.437 |
| PSMB2 | 0.436 |
| COPB1 | 0.435 |
| ISCU | 0.432 |
| CHAF1A | 0.431 |
| CCNA2 | 0.431 |
| LAD1 | 0.43 |
| CBWD6 | 0.427 |
| NOL12 | 0.427 |
| KRT78 | 0.426 |
| GOLGA6L4 | 0.425 |
| ZNF655 | 0.425 |
| VASN | 0.424 |
| ATP6V1B2 | 0.424 |
| NOL9 | 0.423 |
| ZNF830 | 0.423 |
| CDC45 | 0.423 |
| IGFN1 | 0.422 |
| C14orf93 | 0.42 |
| BYSL | 0.417 |
| NPIPB5 | 0.417 |
| TBC1D3I | 0.416 |
| OSBP | 0.415 |
| COX7A2L | 0.415 |
| TBC1D3K | 0.415 |
| TBC1D3E | 0.415 |
| TRAPPC11 | 0.414 |
| TBC1D3L | 0.414 |
| RPL6 | 0.414 |
| CBWD5 | 0.413 |
| GOLGA8O | 0.412 |
| PRIM1 | 0.412 |
| HIVEP3 | 0.412 |
| TBC1D3C | 0.412 |
| PRPF8 | 0.411 |
| CCDC94 | 0.41 |
| RPS2 | 0.41 |
| NBPF16 | 0.41 |
| NCAPG | 0.409 |
| PSMC2 | 0.409 |
| PSMB3 | 0.408 |
| TP53TG3 | 0.408 |
| TP53TG3C | 0.408 |
| TP53TG3B | 0.408 |
| TWISTNB | 0.407 |
| SLC4A1 | 0.407 |
| GOLGA6L1 | 0.407 |
| NUP43 | 0.407 |
| EIF4A3 | 0.405 |
| LRR1 | 0.405 |
| WDR43 | 0.405 |
| C1QTNF9B | 0.405 |
| RRP7A | 0.404 |
| GOLGA6L3 | 0.403 |
| TONSL | 0.401 |
| STRN | 0.401 |
| COPG1 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 415/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 14/28 |
| blood | 19/28 |
| bone | 9/26 |
| breast | 17/33 |
| central nervous system | 33/56 |
| cervix | 2/4 |
| colorectal | 8/17 |
| esophagus | 7/13 |
| fibroblast | 1/1 |
| gastric | 10/16 |
| kidney | 15/21 |
| liver | 12/20 |
| lung | 36/75 |
| lymphocyte | 11/16 |
| ovary | 16/26 |
| pancreas | 10/24 |
| peripheral nervous system | 7/16 |
| plasma cell | 10/15 |
| prostate | 1/1 |
| skin | 13/24 |
| soft tissue | 5/9 |
| thyroid | 0/2 |
| upper aerodigestive | 6/22 |
| urinary tract | 16/29 |
| uterus | 4/5 |
Essentiality in NALM6
- Essentiality Rank: 622
- Expression level (log2 read counts): 6.71
Expression Distribution
SART1 Expression in NALM6 Cells: 6.71